Overview
A one-year programme in evaluating and treating systemic amyloidosis, with exposure to BMT, cellular therapy, cardio-oncology and onco-nephrology and a mentored research project.
The programme
- Training type
- Clinical Fellowship
- Duration
- 1 year, optional 2nd research year
- Start
- July (flexible)
- Positions
- 1
- Accreditation
- Not stated on official page
- Department
- Department of Medicine
Eligibility and visa
- Eligibility
- Completed IM residency and haematology/oncology fellowship (or equivalent); IM graduates intending to apply for hem/onc may be considered
- International applicants
- Foreign applicants with equivalent qualifications are eligible to apply (programme page)
- Visa support
- Not stated on official page
- Licence requirement
- Not stated on official page
How to apply
- Deadline
- 1 May 2026 (for July 2026-June 2027 cycle)
- Application method
- Send updated CV and personal statement to Dr Heather Landau; one letter of recommendation sent directly
Funding
- Funding
- Not stated on official page